Protein microarray is an emerging technology that provides a versatile platform for characterization of thousands of proteins. There are two major classes of protein microarrays namely analytical and functional protein microarrays. Additionally, tissue or cell samples can also be isolated and spotted on a slide to form a reverse-phase protein microarray. While the fabrication technology is maturing, applications of protein microarrays, especially functional protein microarrays have been flourished during the past decade. The research for novel proteins includes detection of various binding properties of proteins, profiling antibody specificity, and biomarkers identification in autoimmune diseases. Protein microarray is a powerful technology platform and is anticipated to be one of the leading technologies in the proteomic and diagnostic fields in the coming years.
Some of key the players in the global protein microarray market are Thermo Fisher Scientific (U.S), Agilent Technologies (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Illumina Inc. (U.S.), Abbott Laboratories (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), SEQUENOM, Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Affymetrix, Inc. (U.S.), EMD Millipore (U.S.), Medtronic Inc. (U.S.), Angioscore Ltd. (U.S.) and others.
Get a sample report at https://www.marketresearchfuture.com/sample_request/5310 .
Global protein microarray consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas are expected to lead the global market due to the high incidence of cancer and infectious diseases. According to the American Cancer Society, more than 1,665,540 new cases of cancers were diagnosed in the U.S. in 2014. While Europe is expected to hold the second largest market share in the global market.
Asia Pacific region is expected to witness significant growth owing to increasing case of cancer and growing awareness regarding the diagnosis of infectious diseases. In addition, increasing healthcare expenditure related to cancer and associated disease is expected to boost the market growth in near future. This has led to an increase in the government spending on healthcare services in India and China.
The global protein microarray is segmented on the basis of type, application, product, technology, and end-users.
On the basis of the type, the global protein microarray market is segmented into protein chips, lab-on-chips (microfluidics), integrated systems, arrayers, and microarray systems.
On the basis of the application, the global protein microarray market is segmented into diagnostics, proteomics, protein functional analysis, and antibody characterization
On the basis of the product, the global protein microarray market is segmented into protein microarray instruments, protein microarray reagents, and protein microarray services.
On the basis of the technology, the global protein microarray market is segmented into analytical microarrays, functional protein microarrays, and reverse phase protein microarray
On the basis of the end user, the global protein microarray market has been segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.
Browse Complete Report at https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378 .
Proteomics instruments, reagents, and testing are needed to discover new biomarkers and even new drugs. The market has crossed 5 billion dollars in 2013. Though a number of tests are available in the market for protein analysis, the microarray is the efficient and fastest revenue generating technique. Improvement in generating high-quality proteins and antibodies will play a key role in the quantitative analysis and promote the extension of this technology to other organisms.
Despite the considerable investments made by several companies, the low availability of proteins in the market. Proteins are highly sensitive to changes in their microenvironment. This presents a challenge in maintaining protein arrays in a stable condition over extended periods of time. Declining production of consistent and reliable proteins due to low yield may hamper the market growth over the forecast period 2017-2023.
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –